US2016331287A1PendingUtilityA1
Devices, Systems, and Methods Related to Analyte Monitoring and Management
Est. expiryApr 22, 2030(~3.8 yrs left)· nominal 20-yr term from priority
Inventors:Jonathan FernMark P. JesserLynn DixonJai KaranCharles WeiMatthew T. VogelTimothy S. GasperakKim CullenKim LadinMarc B. TaubGary Alan Hayter
A61B 5/0022A61B 5/7475A61B 5/746A61B 5/14532A61B 5/742A61B 5/150358G16Z 99/00G16H 40/67A61B 5/72A61B 2560/0295A61B 2560/045A61B 5/14546A61B 5/743A61B 5/7435
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Analyte monitoring devices, systems, and methods are provided that relate to: enabling different application features on a data processing device for analyte monitoring devices with different analyte monitoring features; programming analyte monitoring devices in advance; personalizing an analyte monitoring device; graphically representing a remaining insulin level in a user body; and graphically representing analyte measurement related data for on-demand readings; protecting access to feature of an analyte monitoring device.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . An analyte monitoring device, comprising:
a housing; a strip port coupled to the housing; a processor coupled to the housing; and memory operably coupled to the housing and electrically coupled to the first processor, wherein the memory includes instructions stored therein for programming an analyte monitoring device in advance, the instructions comprising:
instructions for receiving, with a processor on an analyte monitoring device, programming instructions for operating the analyte monitoring device in a first mode beginning at a future point in time, wherein the future point in time is based on an occurrence of an event;
instructions for enabling, with the processor, the operation of the analyte monitoring device in a second mode before the future point in time; and
instructions for enabling, with the processor, the operation of the analyte monitoring device in the first mode beginning at the future point in time.
22 . The analyte monitoring device of claim 21 , wherein the event is a future clinical visit.
23 . The analyte monitoring device of claim 22 , wherein the future point in time is a predetermined amount of time before the clinical visit.
24 . The analyte monitoring device of claim 23 , wherein the operation of the analyte monitoring device in the first mode is enabled for a predetermined duration of time.
25 . The analyte monitoring device of claim 21 , wherein the operation of the analyte monitoring device in the first mode comprises performing analyte measurements and recording the analyte measurements, and operating the analyte monitoring device in the second mode comprises performing analyte measurements without recording the analyte measurements.
26 . The analyte monitoring device of claim 21 , wherein the operation of the analyte monitoring device in the first mode comprises operating in a first data gathering mode, and wherein the operation of the analyte monitoring device in the second mode comprises operating in a second data gathering mode.
27 . The analyte monitoring device of claim 21 , wherein the future point in time is a predetermined amount of time before the event.
28 . The analyte monitoring device of claim 21 , wherein the operation of the analyte monitoring device in the first mode is enabled for a predetermined duration of time.
29 . The analyte monitoring device of claim 21 , wherein the operation in the first mode comprises activating additional user interfaces, reminders, or alarms that are different than in the second mode.
30 . The analyte monitoring device of claim 21 , wherein the analyte is glucose.
31 . The analyte monitoring device of claim 21 , wherein the event is the programming of the analyte monitoring device.
32 . The analyte monitoring device of claim 31 , wherein the future point in time is a predetermined amount of time after the programming of the device.
33 . The analyte monitoring device of claim 21 , wherein the operation in the first mode and second mode comprises operating the analyte monitoring device with different configuration settings.
34 . The analyte monitoring device of claim 21 , wherein the programming instructions are received via the internet.
35 . The analyte monitoring device of claim 21 , wherein the programming instructions are received via a remote data processing device operatively coupled to the analyte monitoring device.
36 . The analyte monitoring device of claim 21 , wherein the event is a future data condition obtained by the analyte monitoring device, and the future point in time is at an occurrence of the future data condition.
37 . The analyte monitoring device of claim 36 , wherein the future data condition is an occurrence of a measurement reading.
38 . The analyte monitoring device of claim 36 , wherein the future data condition is a threshold measurement reading.
39 . The analyte monitoring device of claim 36 , wherein the future data condition is a predetermined trending magnitude.
40 . The analyte monitoring device of claim 36 , wherein the future data condition is an occurrence of a pattern.
41 . The analyte monitoring device of claim 36 , wherein the future data condition is a user-entered condition.
42 . The analyte monitoring device of claim 36 , wherein the operation of the analyte monitoring device in the first mode comprises performing analyte measurements and recording the analyte measurements, and operating the analyte monitoring device in the second mode comprises performing analyte measurements without recording the analyte measurements.
43 . The analyte monitoring device of claim 36 , wherein the operation of the analyte monitoring device in the first mode comprises operating in a first data gathering mode, and wherein the operation of the analyte monitoring device in the second mode comprises operating in a second data gathering mode.
44 . The analyte monitoring device of claim 36 , wherein the operation of the analyte monitoring device in the first mode is enabled for a predetermined duration of time.
45 . The analyte monitoring device of claim 36 , wherein operation in the first mode comprises activating additional user interfaces, reminders, or alarms that are different than in the second mode.
46 . The analyte monitoring device of claim 36 , wherein the analyte is glucose.
47 . The analyte monitoring device of claim 36 , wherein operation in the first mode and second mode comprises operating the analyte monitoring device with different configuration settings.
48 . The analyte monitoring device of claim 36 , wherein the programming instructions are received via the internet.
49 . The analyte monitoring device of claim 36 , wherein the programming instructions are received via a remote data processing device operatively coupled to the analyte monitoring device.
50 - 126 . (canceled)Join the waitlist — get patent alerts
Track US2016331287A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.